Cardiac fibroblasts as sentinel cells in cardiac tissue: Receptors, signaling pathways and cellular functions

Pharmacological Research

Volumn 101, Issue , 2015, Pages 30-40

  Diaz Araya G ^a   Vivar, R ^a   Humeres, C ^a   Boza, P ^a   Bolivar, S ^a   Munoz C ^a  

^a University of Chile   (Chile)

Author keywords

Cardiac fibroblast; Cellular functions; Cytokines; Receptors; Sentinel cells

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; CARRIER PROTEIN; CHEMOKINE; COLLAGEN; CRYOPYRIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYTOKINE; EPAC PROTEIN; GROWTH FACTOR; INTERFERON RECEPTOR; NITRIC OXIDE; PROSTACYCLIN; SCLEROPROTEIN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; ADRENERGIC RECEPTOR; BRADYKININ RECEPTOR; CELL SURFACE RECEPTOR; INFLAMMASOME; TOLL LIKE RECEPTOR;

APOPTOSIS; AUTOPHAGY; CELL ADHESION; CELL DEATH; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CYTOKINE RELEASE; GENE OVEREXPRESSION; HEART FIBROBLAST; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; MYOFIBROBLAST; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; STIMULUS RESPONSE; TISSUE REPAIR; ANIMAL; CARDIAC MUSCLE; CELL MOTION; CYTOLOGY; FIBROBLAST; IMMUNOLOGY; METABOLISM;

ANIMALS; CELL ADHESION; CELL DIFFERENTIATION; CELL MOVEMENT; CYTOKINES; EXTRACELLULAR MATRIX PROTEINS; FIBROBLASTS; HUMANS; INFLAMMASOMES; INFLAMMATION; MYOCARDIUM; MYOFIBROBLASTS; RECEPTORS, ADRENERGIC; RECEPTORS, ANGIOTENSIN; RECEPTORS, BRADYKININ; RECEPTORS, CELL SURFACE; RECEPTORS, INTERFERON; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84945460374     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2015.07.001     Document Type: Review

References (139)

1. J.G. Meszaros, A.M. Gonzalez, Y. Endo-Mochizuki, S. Villegas, F. Villarreal, and L.L. Brunton Identification of G protein-coupled signaling pathways in cardiac fibroblasts: cross talk between G(q) and G(s) Am. J. Physiol. Cell Physiol. 278 1 2000 C154 C162
2. 2+/calmodulin. Gq-Gs cross-talk regulates collagen production in cardiac fibroblasts J. Biol. Chem. 278 27 2003 24461 24468
3. I. Olmedo, C. Muñoz, N. Guzmán, M. Catalán, R. Vivar, P. Ayala, C. Humeres, P. Aránguiz, L. García, V. Velarde, and G. Díaz-Araya EPAC expression and function in cardiac fibroblasts and myofibroblasts Toxicol. Appl. Pharmacol. 272 2 2013 414 422
4. R. Vivar, C. Soto, M. Copaja, F. Mateluna, P. Aranguiz, J.P. Muñoz, M. Chiong, L. Garcia, A. Letelier, W.G. Thomas, S. Lavandero, and G. Díaz-Araya Phospholipase C/proteinkinase C pathwaymediatesangiotensin II-dependent apoptosis in neonatal rat cardiac fibroblasts expressing AT1 receptor J. Cardiovasc. Pharmacol. 52 2 2008 184 190
5. P. Aránguiz-Urroz, J. Canales, M. Copaja, R. Troncoso, J.M. Vicencio, C. Carrillo, H. Lara, S. Lavandero, and G. Díaz-Araya Beta(2)-adrenergic receptor regulates cardiac fibroblast autophagy and collagendegradation Biochim. Biophys. Acta 1812 1 2011 23 31
6. P. Aránguiz-Urroz, D. Soto, A. Contreras, R. Troncoso, M. Chiong, J. Montenegro, D. Venegas, C. Smolic, P. Ayala, W.G. Thomas, S. Lavandero, and G. Díaz-Araya Differential participation of angiotensin II type 1 and 2 receptors in the regulation of cardiac cell death triggered by angiotensin II Am. J. Hypertens. 22 5 2009 569 576
7. M. Catalán, C. Smolic, A. Contreras, P. Ayala, I. Olmedo, M. Copaja, P. Boza, R. Vivar, Y. Avalos, S. Lavandero, V. Velarde, and G. Díaz-Araya Differential regulation of collagen secretion bykinin receptors in cardiac fibroblast and myofibroblast Toxicol. Appl. Pharmacol. 261 3 2012 300 308
8. A.V. Shinde, and N.G. Frangogiannis Fibroblasts in myocardial infarction: a role in inflammation and repair J. Mol. Cell Cardiol. 70 2014 74 82
9. K.E. Porter, and N.A. Turner Cardiac fibroblasts: at the heart of myocardial remodeling Pharmacol. Ther. 123 2 2009 255 278
10. M. Kawaguchi, M. Takahashi, T. Hata, Y. Kashima, F. Usui, H. Morimoto, and et al. Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury Circulation 123 6 2011 594 604
11. S. Van Linthout, K. Miteva, and C. Tschöpe Crosstalk between fibroblasts and inflammatory cells Cardiovasc. Res. 102 2 2014 258 269
12. W. Zhang, X. Xu, R. Kao, T. Mele, P. Kvietys, C.M. Martin, and T. Rui Cardiac fibroblasts contribute to myocardial dysfunction in mice with sepsis: the role of NLRP3 inflammasome activation PLoS One 9 9 2014 e107639
13. O.E. Brodde, H. Bruck, and K. Leineweber Cardiac adrenoceptors: physiological and pathophysiological relevance J. Pharmacol. Sci. 100 2006 323 337
14. S.R. Post, H.K. Hammond, and P.A. Insel Adrenergic receptors and receptor signaling in heart failure Annu. Rev. Pharmacol. Toxicol. 39 1999 343 360
15. Ch.M. Tang, and P.A. Insel GPCR expression in the heart "New" receptors in myocytes and fibroblasts Trends Cardiovasc. Med. 14 2004 94 99
16. M.P. Ocaranza, G. Díaz-Araya, M. Chiong, D. Muñoz, J.P. Riveros, R. Ebensperger, S. Sabat, P. Irarrázaval, J.E. Jalil, and S. Lavandero Influence of isoproterenol on the expression of angiotensin I-converting enzyme in lung, left ventricle and plasma during the development and regression of myocardial hypertrophy and fibrosis J. Cardiovasc. Pharmacol. 40 2002 246 254
17. M.P. Ocaranza, G. Diaz-Araya, J.E. Carreno, D. Munoz, J.P. Riveros, J.E. Jalil, and S. Lavandero A polymorphism in the gene coding for angiotensin converting enzyme determines different development of myocardial fibrosis in the rat Am. J. Physiol. Heart Circ. Physiol. 286 2004 H498 H506
18. M. Copaja, R. Valenzuela, A. Saldaña, M.P. Ocaranza, J.E. Jalil, C. Vio, P. Lijnen, G.E. Ordenes, R. Vivar, S. Lavandero, and G. Díaz-Araya Early expression of monocyte chemoattractant protein-1 correlates with the onset of isoproterenol induced cardiac fibrosis in rats with distinct angiotensin-converting enzyme polymorphism JRAAS 9 2008 154 162
19. Y. Sun, and K.T. Weber Animal models of cardiac fibrosis Methods Mol. Med. 117 2005 273 290
20. K.T. Weber Fibrosis in hypertensive Heart disease: focus on cardiac fibroblast J. Hypertens. 22 2004 47 50
21. N.A. Turner, K.E. Porter, W.H. Smith, H.L. White, S.G. Ball, and A.J. Balmforth Chronic beta2-adrenergic receptor stimulation increases proliferation of human cardiac fibroblasts via an autocrine mechanism Cardiovasc. Res. 57 2003 784 792
22. K. Iizuka, H. Sano, H. Kawaguchi, and A. Kitabatake Transforming growth factor beta-1 modulates the number of beta-adrenergic receptors in cardiac fibroblasts J. Mol. Cell Cardiol. 26 1994 435 440
23. S.S. Roscioni, C.R. Elzinga, and M. Schmidt Epac: effectors and biological functions Naunyn-Schmiedeberg's Arch. Pharmacol. 377 2008 345 357
24. J.L. Bos Epac: a new cAMP target and new avenues in cAMP research Nat. Rev. Mol. Cell Biol. 4 2003 733 738
25. G.G. Holz, G. Kang, M. Harbeck, M.W. Roe, and O.G. Chepurny Cell physiology of cAMP sensor Epac J. Physiol. 577 2006 5 15
26. J.L. Bos Epac proteins: multi-purpose cAMP targets Trends Biochem. Sci. 1 2006 680 686
27. F. Colombo, J. Noël, P. Mayers, I. Mercier, and A. Calderone Beta-adrenergic stimulation of rat cardiac fibroblasts promotes protein synthesis via the activation of phosphatidylinositol 3-kinase J. Mol. Cell Cardiol. 33 2001 1091 1106
28. J.S. Swaney, D.M. Roth, E.R. Olson, J.E. Naugle, J.G. Meszaros, and P.A. Insel Inhibition of cardiac myofibroblast formation and collagen synthesis by activation and overexpression of adenylyl cyclase Proc. Natl. Acad. Sci. 102 2005 437 442
29. T. Mio, X.D. Liu, Y. Adachi, I. Striz, C.M. Sköld, D.J. Romberger, J.R. Spurzem, M.G. Illig, R. Ertl, and S.I. Rennard Human bronchial epithelial cells modulate collagen gel contraction by fibroblasts Am. J. Physiol. 274 1998 L119 L126
30. M. Leicht, N. Greipel, and H. Zimmer Comitogenic effect of catecholamines on rat cardiac fibroblasts in culture Cardiovasc. Res. 48 2000 274 284
31. U. Yokoyama, H.H. Patel, N. Ch. Lai, N. Aroonsakool, D.M. Roth, and P.A. Insel The cyclic AMP effector Epac integrates pro- and anti-fibrotic signals PNAS 105 2008 6386 6391
32. X. Liu, S.Q. Sun, A. Hassid, and R.S. Ostrom cAMP inhibits transforming growth factorbeta-stimulated collagen synthesis via inhibition of extracellular signal-regulated kinase and Smad signaling in cardiac fibroblasts Mol. Pharmacol. 70 2006 1992 2003
33. D. Grimm, M. Huber, H.C. Jabusch, M. Shakibaei, S. Fredersdorf, M. Paul, G.A. Riegger, and E.P. Kromer Extracellular matrix proteins in cardiac fibroblasts derived from rat hearts with chronic pressure overload: effects of beta-receptor blockade J. Mol. Cell Cardiol. 33 2001 487 501
34. C.E. Pullar, C.G. Manabat-Hidalgo, R.S. Bolaji, and R.R. Isseroff β-Adrenergic receptor modulation of wound repair Pharmacol. Res. 58 2008 158 164
35. C.E. Pullar, A. Rizzo, and R.R. Isseroff Beta-adrenergic receptor antagonists accelerate skin wound healing JBC 281 2006 21225 21235
36. N.G. Frangogiannis The inflammatory response in myocardial injury, repair, and remodeling Nat. Rev. Cardiol. 11 5 2014 255 265
37. N.G. Frangogiannis Regulation of the inflammatory response in cardiac repair Circ. Res. 110 1 2012 159 173
38. A. Bürger, M. Benicke, A. Deten, and H.G. Zimmer Catecholamines stimulate interleukin-6 synthesis in rat cardiac fibroblasts Am. J. Physiol. Heart Circ. Physiol. 281 1 2001 H14 H21
39. C. Chen, J. Du, W. Feng, Y. Song, Z. Lu, M. Xu, Z. Li, and Y. Zhang β-Adrenergic receptors stimulate interleukin-6 production through Epac-dependent activation of PKCδ/p38 MAPK signalling in neonatal mouse cardiac fibroblasts Br. J. Pharmacol. 166 2 2012 676 688
40. P. Timmermans, P. Benfield, and A.T. Chiu Angiotensin II receptors and functional correlates Am. J. Hypertens. 5 1992 221 235
41. R. Zhang, Y.Y. Zhang, and X.R. Huang C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease Hypertension 55 2010 953 960
42. M. De Gasparo, K.J. Catt, T. Inagami, J.W. Wright, and T. Unger International union of pharmacology. XXIII. The angiotensin II receptors Pharmacology 52 3 2000 415 472
43. F.J. Villarreal, N.N. Kim, G.D. Ungab, M.P. Printz, and W.H. Dillmann Identification of functional angiotensin II receptors on rat cardiac fibroblasts Circulation 88 6 1993 2849 2861
44. X.Q. Chen, X. Liu, Q.X. Wang, M.J. Zhang, and M. Guo Pioglitazone inhibits angiotensin II-induced atrial fibroblasts proliferation via NF-κB/TGF-β1/TRIF/TRAF6 pathway Exp. Cell. Res. 330 1 2015 43 55
45. Y. Ikeda, T. Nakamura, H. Takano, H. Kimura, J.E. Obata, S. Takeda, A. Hata, K. Shido, S. Mochizuki, and Y. Yoshida Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats J. Lab. Clin. Med. 135 4 2000 353 359
46. C. Warnecke, D. Kaup, U. Marienfeld, W. Poller, C. Yankah, M. Gräfe, E. Fleck, and V. Regitz-Zagrosek Adenovirus-mediated overexpression and stimulation of the human angiotensin II type 2 receptor in porcine cardiac fibroblasts does not modulate proliferation, collagen I mRNA expression and ERK1/ERK2 activity, but inhibits protein tyrosine phosphatases J. Mol. Med. 79 9 2001 510 521
47. S. Staufenberger, M. Jacobs, K. Brandstätter, M. Hafner, V. Regitz-Zagrosek, G. Ertl, and W. Schorb Angiotensin II type 1 receptor regulation and differential trophic effects on rat cardiac myofibroblasts after acute myocardial infarction J. Cell. Physiol. 187 3 2001 326 335
48. J. Bai, N. Zhang, Y. Hua, B. Wang, L. Ling, A. Ferro, and B. Xu Metformin inhibits angiotensin II-induced differentiation of cardiac fibroblasts into myofibroblasts PLoS One 8 9 2013 e72120
49. X. Wang, J. Lu, M. Khaidakov, S. Mitra, Z. Ding, S. Raina, T. Goyal, and J.L. Mehta Aspirin suppresses cardiac fibroblast proliferation and collagen formation through downregulation of angiotensin type 1 receptor transcription Toxicol. Appl. Pharmacol. 259 3 2012 346 354
50. A. Whaley-Connell, J. Habibi, S.A. Cooper, V.G. Demarco, M.R. Hayden, C.S. Stump, D. Link, C.M. Ferrario, and J.R. Sowers Effect of renin inhibition and AT1R blockade on myocardial remodeling in the transgenic Ren2 rat Am. J. Physiol. Endocrinol. Metab. 1 3 2008 E103 E109
51. M. Liu, Z. Li, G.W. Chen, Z.M. Li, L.P. Wang, J.T. Ye, H.B. Luo, and P.Q. Liu AG-690/11026014, a novel PARP-1 inhibitor, protects cardiomyocytes from Ang II-induced hypertrophy Mol. Cell Endocrinol. 392 1-2 2014 14 22
52. W. Zhang, X.F. Chen, Y.J. Huang, Q.Q. Chen, Y.J. Bao, and W. Zhu 2,3,4′,5-Tetrahydroxystilbene-2-O-β-d-glucoside inhibits angiotensin II-induced cardiac fibroblast proliferation via suppression of the reactive oxygen species-extracellular signal-regulated kinase 1/2 pathway Clin. Exp. Pharmacol. Physiol. 39 5 2012 429 437
53. J. Gu, X. Liu, Q.X. Wang, H.W. Tan, M. Guo, W.F. Jiang, and L. Zhou Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts Exp. Cell Res. 318 16 2012 2105 2115
54. T.M. Gwathmey, E.M. Alzayadneh, K.D. Pendergrass, and M.C. Chappell Novel roles of nuclear angiotensin receptors and signaling mechanisms Am. J. Physiol. Regul. Integr. Comp. Physiol. 302 5 2012 R518 R530
55. C.E. Squires, G.P. Escobar, J.F. Payne, R.A. Leonardi, D.K. Goshorn, N.J. Sheats, I.M. Mains, J.T. Mingoia, E.C. Flack, and M.L. Lindsey Altered fibroblast function following myocardial infarction J. Mol. Cell. Cardiol. 39 4 2005 699 707
56. P.A. Galie, M.W. Russell, M.V. Westfall, and J.P. Stegemann Interstitial fluid flow and cyclic strain differentially regulate cardiac fibroblast activation via AT1R and TGF-β1 Exp. Cell Res. 318 1 2012 75 84
57. A. Leask Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation Circ. Res. 106 11 2010 1675 1680
58. M. Iwamoto, S. Hirohata, H. Ogawa, T. Ohtsuki, R. Shinohata, T. Miyoshi, F.O. Hatipoglu, S. Kusachi, K. Yamamoto, and Y. Ninomiya Connective tissue growth factor induction in a pressure-overloaded heart ameliorated by the angiotensin II type 1 receptor blocker olmesartan Hypertens. Res. 33 12 2010 1305 1311
59. N.L. Rosin, A. Falkenham, M.J. Sopel, T.D. Lee, and J.F. Légaré Regulation and role of connective tissue growth factor in AngII-induced myocardial fibrosis Am. J. Pathol. 182 3 2013 714 726
60. H. Kawano, Y.S. Do, Y. Kawano, V. Starnes, M. Barr, R.E. Law, and W.A. Hsueh Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts Circulation 101 10 2000 1130 1137
61. J.M. Schnee, and W.A. Hsueh Angiotensin II, adhesion, and cardiac fibrosis Cardiovasc. Res. 46 2 2000 264 268
62. J.M. Siddesha, A.J. Valente, T. Yoshida, S.S. Sakamuri, P. Delafontaine, H. Iba, M. Noda, and B. Chandrasekar Docosahexaenoic acid reverses angiotensin II-induced RECK suppression and cardiac fibroblast migration Cell Signal. 26 5 2014 933 941
63. Y. Tsutsumi, H. Matsubara, N. Ohkubo, Y. Mori, Y. Nozawa, S. Murasawa, K. Kijima, K. Maruyama, H. Masaki, Y. Moriguchi, Y. Shibasaki, H. Kamihata, M. Inada, and T. Iwasaka Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression Circ. Res. 83 1998 1035 1046
64. E.S. Jones, M.J. Black, and R.E. Widdop Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade J. Mol. Cell Cardiol. 37 2004 1023 1030
65. S. Kurisu, R. Ozono, T. Oshima, M. Kambe, T. Ishida, H. Sugino, H. Matsuura, K. Chayama, Y. Teranishi, O. Iba, K. Amano, and H. Matsubara Cardiac angiotensin II type 2 receptor activates the kinin/NO system and inhibits fibrosis Hypertension 41 2003 99 107
66. M.P. Ocaranza, J. Moya, V. Barrientos, R. Alzamora, D. Hevia, C. Morales, M. Pinto, N. Escudero, L. García, U. Novoa, P. Ayala, G. Díaz-Araya, I. Godoy, M. Chiong, S. Lavandero, J.E. Jalil, and L. Michea Angiotensin-(1-9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis J. Hypertens. 32 4 2014 771 783
67. J.L. Miguel-Carrasco, S. Zambrano, A.J. Blanca, A. Mate, and C.M. Vázquez Captopril reduces cardiac inflammatory markers in spontaneously hypertensive rats by inactivation of NF-kB J. Inflamm. 7 2010 21
68. C. Duerrschmid, J. Trial, Y. Wang, M.L. Entman, and S.B. Haudek Tumor necrosis factor: a mechanistic link between angiotensin-II-Induced cardiac inflammation and fibrosis Circ. Heart Fail. 8 2 2015 352 361
69. H. Sato, A. Watanabe, T. Tanaka, N. Koitabashi, M. Arai, M. Kurabayashi, and T. Yokoyama Regulation of the human tumor necrosis factor-alpha promoter by angiotensin II and lipopolysaccharide in cardiac fibroblasts: different cis-acting promoter sequences and transcriptional factors J. Mol. Cell Cardiol. 35 10 2003 1197 1205
70. P.G. McLean, M. Perretti, and A. Ahluwalia Kinin B(1) receptors and the cardiovascular system: regulation of expression and function Cardiovasc. Res. 48 2000 194 210
71. D.J. Campbell The kallikrein-kinin system in humans Clin. Exp. Pharmacol. Physiol. 28 2001 1060 1065
72. H. Yoshida, J.J. Zhang, L. Chao, and J. Chao Kallikrein gene delivery attenuates myocardial infarction and apoptosis after myocardial ischemia and reperfusion Hypertension 35 2000 25 31
73. D. Regoli, and J. Barabé Pharmacology of bradykinin and related kinins Pharmacol. Rev. 32 1980 1 46
74. F. Marceau, J.F. Hess, and D.R. Bachvarov The B1 receptors for kinins Pharmacol. Rev. 50 1998 357 386
75. R. Maestri, A.F. Milia, M.B. Salis, G. Graiani, C. Lagrasta, M. Monica, D. Corradi, C. Emanueli, and P. Madeddu Cardiac hypertrophy and microvascular deficit in kinin B2 receptor knockout mice Hypertension 41 2003 1151 1155
76. L.M. Leeb-Lundberg, F. Marceau, W. Muller-Esterl, D.J. Pettibone, and B.L. Zuraw International union of pharmacology. XLV, classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences Pharmacol. Rev. 57 2005 27 77
77. F. Marceau, J.F. Larrivée, E. Saint-Jacques, and D.R. Bachvarov The kinin B1 receptor: an inducible G protein coupled receptor Can. J. Physiol. Pharmacol. 75 1997 725 730
78. C. Tschöpe, S. Heringer-Walther, and T. Walther Regulation of the kinin receptors after induction of myocardial infarction Braz. J. Med. Biol. Res. 33 2000 701 708
79. F.J. Villarreal, T. Bahnson, and N.N. Kim Human cardiac fibroblasts and receptors for angiotensin II and bradykinin: a potential role for bradykinin in the modulation of cardiac extracellular matrix Basic Res. Cardiol. 93 1998 4 7
80. M.E. Moreau, N. Garbacki, G. Molinaro, N.J. Brown, F. Marceau, and A. Adam The kallikrein-kinin system: current and future pharmacological targets J. Pharmacol. Sci. 99 2005 6 38
81. V. Velarde, M.E. Ullian, T.A. Morinelli, R.K. Mayfield, and A.A. Jaffa Mechanisms of MAPK activation by bradykinin in vascular smooth muscle cells Am. J. Physiol. 277 1999 C253 C261
82. H. Ju, V.J. Venema, H. Liang, M.B. Harris, R. Zou, and R.C. Venema Bradykinin activates the Janus-activated kinase/signal transducers and activators of transcription (JAK/STAT) pathway in vascular endothelial cells: localization of JAK/STAT signaling proteins in plasmalemmal caveolae Biochem. J. 351 2000 257 264
83. 2+ signaling in single cultured vascular smooth muscle cells Mol. Pharmacol. 50 1996 128 139
84. M. Kobara, T. Tatsumi, D. Kambayashi, A. Mano, S. Yamanaka, J. Shiraishi, N. Keira, S. Matoba, J. Asayama, S. Fushiki, and M. Nakagawa Effects of ACE inhibition on myocardial apoptosis in an ischemia-reperfusion rat heart model J. Cardiovasc. Pharmacol. 41 2003 880 889
85. M. Sato, R.M. Engelman, H. Otani, N. Maulik, J.A. Rousou, and J.E. Flack Myocardial protection by preconditioning of heart with losartan, an angiotensin II type 1-receptor blocker: implication of bradykinin-dependent and bradykinin-independent mechanisms Circulation 102 2000 III346 III351
86. A. Mailloux, B. Deslandes, M. Vaubourdolle, and B. Baudin Captopril and enalaprilat decrease antioxidant defences in human endothelial cells and are unable to protect against apoptosis Cell Biol. Int. 27 2003 825 830
87. S. Der Sarkissian, E.L. Marchand, D. Duguay, P. Hamet, and D. deBlois Reversal of interstitial fibroblast hyperplasia via apoptosis in hypertensive rat heart withvalsartan or enalapril Cardiovasc. Res. 7 2003 5775 5783
88. G.C. We, M.G. Siroi, R. Qu, P. Liu, and J.L. Roulea Effects of quinapril on myocardial function, ventricular remodeling and cardiac cytokine expression in congestive heart failure in the rat Cardiovasc. Drugs Ther. 16 2002 29 36
89. A.M. Gallagher, H. Yu, and M.P. Printz Bradykinin-induced reductions in collagen gene expression involve prostacyclin Hypertension 32 1998 84 88
90. N.N. Kim, S. Villegas, S.R. Summerour, and F.J. Villarreal Regulation of cardiac fibroblast extracellular matrix production by bradykinin and nitric oxide J. Mol. Cell Cardiol. 31 1999 457 466
91. C. Imai, A. Okamura, J.F. Peng, Y. Kitamura, and M.P. Printz Interleukin-1beta enhanced action of kinins on extracellular matrix of spontaneous hypertensive rat cardiac fibroblasts Clin. Exp. Hypertens. 27 1 2005 59 69
92. M.T. Bawolak, K. Touzin, M.E. Moreau, A. Désormeaux, A. Adam, and F. Marceau Cardiovascular expression of inflammatory signaling molecules, the kinin B1 receptor and COX2, in the rabbit: effects of LPS, anti-inflammatory and anti-hypertensive drugs Regul. Pept. 146 2008 157 168
93. Y.Z. Mozow, and Z. Cuihua Ischemia/reperfusion injury: the role of immune cells World J. Cardiol. 2 10 2010 325 332
94. S. Akira Mammalian toll-like receptors Curr. Opin. Immunol. 15 1 2003 5 11
95. W. Chen, and N.G. Frangogiannis Fibroblasts in post-infarction inflammation and cardiac repair Biochim. Biophys. Acta 1833 4 2013 945 953
96. I. Sabroe, L.C. Parker, S.K. Dower, and M.K. Whyte The role of TLR activation in inflammation J. Pathol. 214 2 2008 126 135
97. S. Frantz, G. Ertl, and J. Bauersachs Mechanisms of disease: toll-like receptors in cardiovascular disease Nat. Clin. Pract. Cardiovasc. Med. 4 8 2007 444 454
98. S. Frantz, L. Kobzik, Y.D. Kim, R. Fukazawa, R. Medzhitov, R.T. Lee, and R.A. Kelly Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium J. Clin. Invest. 104 3 1999 271 280
99. A. Riad, S. Jager, M. Sobirey, F. Escher, A. Yaulema-Riss, D. Westermann, A. Karatas, M.M. Heimesaat, S. Bereswill, D. Dragun, M. Pauschinger, H.P. Schultheiss, and C. Tschope Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice J. Immunol. 180 10 2008 6954 6961
100. B. Dybdahl, A. Wahba, E. Lien, T.H. Flo, A. Waage, N. Qureshi, O.F. Sellevold, T. Espevik, and A. Sundan Inflammatory response after open heart surgery: release of heat-shock protein 70 and signaling through toll-like receptor-4 Circulation 105 6 2002 685 690
101. S. Akira, and K. Takeda Toll-like receptor signaling Nat. Rev. Immunol. 4 7 2004 499 511
102. S. Mariathasan, D.S. Weiss, K. Newton, J. McBride, K. O'Rourke, M. Roose -Girma, and et al. Cryopyrin activates the inflammasome in response to toxins and ATP Nature 440 7081 2006 228 232
103. F. Martinon, V. Pétrilli, A. Mayor, A. Tardivel, and J. Tschopp Gout-associated uric acid crystals activates the NALP3 inflammasome Nature 40 7081 2006 237 241
104. P. Duewell, H. Kono, K.J. Rayner, C.M. Sirois, G. Vladimer, F.G. Bauernfeind, and et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals Nature 464 7293 2010 1357 1361
105. C. Dostert, V. Pétrilli, R. Van Bruggen, C. Steele, B.T. Mossman, and J. Tschopp Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica Science 320 5876 2008 674 677
106. ∅. Sandanger, T. Ranheim, L.E. Vinge, M. Bliksøen, K. Alfsnes, A.V. Finsen, and et al. The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury Cardiovasc. Res. 99 1 2013 164 174
107. N.A. Bracey, B. Gershkovich, J. Chun, A. Vilaysane, H.C. Meijndert, J.R. Wright, and et al. Mitochondrial NLRP3 protein induces reactive oxygen species to promote Smad protein signaling and fibrosis independent from the inflammasome J. Biol. Chem. 289 28 2014 19571 19584
108. S.J. Noppert, K.A. Fitzgerald, and P.J. Hertzog The role of type I interferons in TLR responses Immunol. Cell Biol. 85 2007 446 457
109. L. Ivashkiv, and L. Donlin Regulation of type I interferon responses Immunology 14 2014 36 49
110. S.E. Applequist, and et al. Variable expression of toll-like receptor in murine innate and adaptive immune cell lines Int. Immunol. 14 2002 1065 1074
111. N.A. De Weerd, and T. Nguyen The interferons and their receptors-distribution and regulation Immunol. Cell Biol. 90 2012 483 491
112. L.C. Platanias Mechanisms of type-I and type-II-interferon-mediated signaling Nat. Rev. Immunol 5 5 2005 375 386
113. J. Zurney, K.E. Howard, and B. Sherry Basal expression levels of IFNAR and JAK-STAT components are determinants of cell-type-specific differences in cardiac antiviral responses J. Virol. 81 24 2007 13668 13680
114. S.F. Steinberg Cardiac actions of protein kinase C isoforms Physiology (Bethesda) 27 2012 130 139
115. J. Ivaska, L. Bosca, and P.J. Parker PKC epsilon is a permissive link in integrin-dependent IFN-gamma signalling that facilitates JAK phosphorylation of STAT1 Nat. Cell Biol. 5 2003 363 369
116. S.P. Levick, and P.H. Goldspink Could interferon-gamma be a therapeutic target for treating heart failure? Heart Fail. Rev. 19 2 2014 227 236
117. Y.L. Han, Y.L. Li, L.X. Jia, J.Z. Cheng, Y.F. Qi, H.J. Zhang, and et al. Reciprocal interaction between macrophages and T cells stimulates IFN-gamma and MCP-1 production in Ang II-induced cardiac inflammation and fibrosis PLoS One 7 2012 e35506
118. L. Marko, H. Kvakan, J.K. Park, F. Qadri, B. Spallek, K.J. Binger, E.P. Bowman, M. Kleinewietfeld, V. Fokuhl, R. Dechend, and D.N. Muller Interferon-gamma signaling inhibition ameliorates angiotensin II-induced cardiac damage Hypertension 60 2012 1430 1436
119. K. Savvatis, K. Pappritz, P.M. Becher, D. Lindner, C. Zietsch, H.D. Volk, D. Westermann, H.P. Schultheiss, and C. Tschöpe Interleukin-23 deficiency leads to impaired wound healing and adverse prognosis after myocardial infarction Circ. Heart Fail. 7 1 2014 161 171
120. H.Y. Rao, L. Wei, J.H. Wang, R. Fei, D. Jiang, Q. Zhang, H.S. Chen, and X. Cong Inhibitory effect of human interferon-beta-1a on activated rat and human hepatic stellate cells J. Gastroenterol. Hepatol. 25 11 2010 1777 1784
121. P. Fischer, and D. Hilfiker-Kleiner Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis Basic Res. Cardiol. 102 2007 279 297
122. K. Yamauchi-Takihara gp130-Mediated pathway and heart failure Future Cardiol. 4 2008 427 437
123. R. Bolli, B. Dawn, and Y.T. Xuan Role of the JAK-STAT pathway in protection against myocardial ischemia/reperfusion injury Trends Cardiovasc. Med. 13 2003 72 79
124. I. Rauch, M. Müller, and T. Decker The regulation of inflammation by interferons and their STATs JAK/STAT 2 1 2013 e23820
125. J. Tschopp, and K. Schroder NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production Nat. Rev. Immunol. 10 2010 210 215
126. G. Guarda, M. Braun, F. Staehli, A. Tardivel, C. Mattmann, I. Förster, and et al. Type I interferon inhibits interleukin-1 production and inflammasome activation Immunity 34 2011 213 223
127. S. Epelman, P. Liu, and D. Mann Role of innate and adaptive immune mechanisms in cardiac injury and repair Nat. Rev. Immunol. 15 2015 117 129
128. J. Virag, and C. Murry Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair Am. J. Pathol. 163 2003 2433 2440
129. J.E. Cartledge, C. Kane, P. Dias, M. Tesform, L. Clarke, B. Mckee, S. Al Ayoubi, A. Chester, M.H. Yacoub, P. Camelliti, and C.M. Terracciano Functional crosstalk between cardiac fibroblasts and adult cardiomyocytes by soluble mediators Cardiovasc. Res. 105 2015 260 270
130. M. Lech, and H. Anders Macrophages and fibrosis: how resident and infiltrating mononuclear phagocytes orchestrate all phases of tissue injury and repair Biochim. Biophys. Acta 1832 2013 989 997
131. N.W. Lukacs, S.L. Kunkel, R. Allen, H.L. Evanoff, C.L. Shaklee, J.S. Sherman, M.D. Burdick, and R.M. Strieter Stimulus and cell-specific expression of C-X-C and C-C chemokines by pulmonary stromal cell populations Am. J. Physiol. 268 1995 856 861
132. M.J. Yellin, S. Winikoff, S.M. Fortune, D. Baum, M.K. Crow, S. Lederman, and L. Chess Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 up-regulation and IL-6 production and proliferation J. Leukoc. Biol. 58 1995 209 216
133. Y. Seko, N. Takahashi, M. Azuma, H. Yagita, and K. Okumura Yakaz Expression of costimulatory molecule CD40 in murine heart with acute myocarditis and reduction of inflammation by treatment with anti-CD40L/B7-1 monoclonal antibodies Circ. Res. 83 1998 463 469
134. R. Kacimi, J.S. Karliner, F. Kouddsi, and C.S. Long Expression and regulation of adhesion molecules in cardiac cells by cytokines Circ. Res. 82 1998 576 586
135. P. Couture, J. Paradis-Massie, N.N. Oualha, and G. Thibault Adhesion and transcellular migration of neutrophils and B lymphocytes on fibroblasts Exp. Cell. Res. 315 2009 2192 2206
136. G. Parsonage, A.D. Filer, O. Haworth, G.B. Nash, G.E. Rainger, M. Salmon, and C.D. Buckley A stromal address code defined by fibroblasts Trends Immunol. 26 2005 150 156
137. T. Silzle, G.J. Randolph, M. Kreutz, and L.A. Kunz-Schughart The Fibroblast: sentinel cell and local immune modulator in tumor tissue Int. J. Cancer 108 2004 173 180
138. D. Lindner, C. Zietsch, J. Tank, S. Sosalla, N. Fluschnick, S. Hinrichs, L. Maier, W. Poller, S. Blankerberg, H.P. Schultheiss, C. Tschope, and D. Westermann Cardiac fibroblasts support cardiac inflammation in heart failure Basic Res. Cardiol. 109 2014 428
139. C.D. Buckley, D. Pilling, J.M. Lord, A.N. Akbar, D. Scheel-Toellner, and M. Salmon Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation Trends Immunol. 22 2001 199 204